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SUMMARY
Pantoea vagans C9-1 is one of the most effective and 
reliable biocontrol agents against fire blight, and has been 
commercialized as Blight Ban C9-1. Production of mul-
tiple antibiotics contributes to its antagonism of Erwinia 
amylovora. Here we describe the genetics, chemical isola-
tion and structure of herbicolin O, the histidine-reversible 
antibiotic produced by P. vagans C9-1. Mutational analyses 
indicated that biosynthesis of herbicolin O depends on 
paaAB and a sequence encoding the peptide precursor of 
pantocin A. The paaABC gene cluster encoding biosynthe-
sis and autoresistance was located within a 28-kb chromo-
somal genomic island of the complete genome sequence 
of P. vagans C9-1. The cluster was cloned and expressed in 
E. coli and purified antibiotic was isolated using improved 
methods for small peptides. The 1H NMR spectra of the 
C9-1 antibiotic closely resembled those of pantocin A pro-
duced by P. agglomerans Eh318. Detailed analysis of the 
proton spin systems showed that the chemical shift values 
and coupling constants of the protons in C9-1 herbicolin O 
correspond exactly to those of pantocin A. Based on these 
genetic and chemical analyses, herbicolin O and pantocin 
A are confirmed to be the same antibiotic.
Keywords: fire blight, biocontrol, herbicolin O, peptide 
antibiotic.
INTRODUCTION
The genus Pantoea has proven to be a significant source 
for excellent biological control agents of fire blight, caused 
by Erwinia amylovora. Some of these have been developed 
into commercially available products for use in the USA 
and Canada. Representatives of Pantoea species produce a 
range of potent antimicrobial agents, including the peptide 
antibiotics herbicolin A and B, which inhibit fungi and 
sterol-requiring mycoplasmas (Freund, 1984, Winkelmann, 
1980), novel b-lactam antibiotics (Kearns, 1998, Parker et 
al., 1982), pyrrolnitrin (Chernin et al., 1996), and a novel 
phenazine (Giddens et al., 2002). In addition, there is a 
large body of literature describing antimicrobial activity 
of antibiotics produced by Pantoea agglomerans strains se-
lected as biological control agents for agriculture. Some 
affect only closely related species, while others inhibit the 
growth of a wide range of bacteria outside of the Entero-
bacteriaceae, including Gram-positive bacteria. Antibiotics 
produced by plant-associated strains have been broadly 
classified on the basis of inactivation by certain amino ac-
ids (Wodzinski and Paulin, 1994). For example, several 
strains of P. agglomerans produce antibiotics that are inac-
tivated in the presence of histidine (Ishimaru et al., 1988; 
Wodzinski and Paulin, 1994; Wright et al., 2001). One of 
these, pantocin A, was isolated from P. agglomerans Eh318 
(Jin et al., 2003). Pantocin A is a novel peptide-derived 
antibiotic inhibiting histidine biosynthesis. The complete 
synthesis and characterization of pantocin B, another an-
tibiotic from P. agglomerans Eh318, has also been reported 
(Brady et al., 1999; Sutton and Clardy, 1999). Pantocin B 
activity is suppressed in the presence of arginine and its 
mode of action targets arginine biosynthesis. Pantocins 
A and B are structurally unique from one another and 
represent two classes of low molecular weight antibiotics. 
Both pantocin A and B are taken up by cells through the 
tripeptide transporter system and inhibit amino acid bio-
synthesis in sensitive organisms (Jin et al., 2003).
One of the first and most effective biological control 
agents described for the control of fire blight is Pantoea 
vagans C9-1 (formerly E. herbicola and P. agglomerans) 
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(Gavini et al., 1989; Rezzonico et al., 2010; Smits et al., 
2011; Brady et al., 2009; Ishimaru et al., 1988). P. vagans 
C9-1 produces at least two antibiotics, originally referred 
to as herbicolin I and O which are active in vitro and in 
immature pear assays against E. amylovora (Ishimaru et 
al., 1988, Kamber et al., 2012). Another antibiotic, herbi-
colin 2C, was detected during the isolation of herbicolin 
I and herbicolin O but has not been characterized fur-
ther. Structurally, herbicolin I is identical to 2-amino-
3-(oxirane-2,3-dicarboxamido)-propanoyl-valine (APV), 
which is produced by P. agglomerans 48b/90 (Sammer et 
al., 2009; Kamber et al., 2012). APV contributes to growth 
inhibition of E. amylovora in flowers in a temperature-de-
pendent manner (Sammer et al., 2012). Plasposon muta-
genesis and complete genome sequencing of P. vagans C9-1 
located the biosynthetic genes for herbicolin I on the 166-
kb plasmid pPag2, (Smits et al., 2011; Kamber et al., 2012; 
Smits et al., 2010). Orthologous gene clusters for herbico-
lin I biosynthesis are present in P. agglomerans CU0119, 
which produces a family of dapdiamide antibiotics (dap-
diamide A to E) and in Serratia proteamaculans (Dawlaty 
et al., 2010; Kamber et al., 2012). Overall, the herbicolin 
I/APV biosynthetic cluster is uncommon among Pantoea 
spp. from biocontrol, environmental, and clinical origins 
(Palmer et al., 2016).
In contrast to herbicolin I, a concise summary of the 
chemical structure and genetics of herbicolin O from P. 
vagans C9-1 is lacking. Like many of the antimicrobial 
activities described from large scale in vitro screens for 
fire blight biocontrol agents, the activity of herbicolin O is 
reversed in the presence of histidine (Ishimaru et al., 1988; 
Vanneste et al., 2008; Wodzinski and Paulin, 1994). Herbi-
colin O is less stable than herbicolin I and is destroyed by 
acidic and basic conditions and high temperatures (Ishi-
maru et al., 1988). These features are also general char-
acteristics of pantocin A, the histidine-reversed antibiotic 
produced by P. agglomerans Eh318 (Jin et al., 2003; Wright 
et al., 2001). Moreover, the genome of P. vagans C9-1 con-
tains an orthologous cluster of genes identified as impor-
tant in the biosynthesis of pantocin A by P. agglomerans 
Eh318 and another histidine-sensitive antibiotic producing 
strain, MccEh252 (Vanneste et al., 2008). While it is pos-
sible that herbicolin O and pantocin A are the same antibi-
otics, direct structural and genetic evidence in support of 
this has not been provided. The purpose of this study was 
to identify the chemical structure of the histidine-sensitive 
antibiotic produced by P. vagans C9-1 and to identify the 
genes required for herbicolin O biosynthesis. Based on our 
findings we conclude that the antibiotic herbicolin O is the 
same as pantocin A.
MATERIALS AND METHODS
Bacterial strains and media. Pantoea vagans strain C9-
1 was isolated previously from Malus pumila cv. Jonathan 
stem tissue (Ishimaru et al., 1988). Erwinia amylovora 
strains resistant to one or more of the antibiotics produced 
by P. vagans C9-1 were previously described (Ishimaru et 
al., 1988). E. amylovora CIR556 is a spontaneous rifampi-
cin resistant mutant of E. amylovora Ea110 (Ishimaru et al., 
1988). Bacteria were maintained as stored stocks in glyc-
erol at −80°C. All bacteria were inoculated directly from 
frozen stocks onto Luria-Bertani (LB) agar plates. P. vagans 
C9-1 and E. amylovora strains were incubated at 26°C for 
24 h. Escherichia coli strains were incubated on LB agar 
and incubated at 37°C for 24 h. Media were supplemented 
as appropriate with antibiotics at the following final con-
centrations: kanamycin (Km) 50 μg/ml, rifampicin (Rf) 
25 μg/ml, tetracycline (Tc) 20 μg/ml. Antibiotic produc-
tion assays were performed on MGA (morpholino-propane 
sulfonic acid buffered medium containing 10 mM potas-
sium gluconate, 10 mM L-asparagine, 10 mM thiamine and 
10 mM nicotinic acid) (Ishimaru et al., 1988).
Antibiotic bioassay. Antimicrobial activities of cells of 
wild type and mutants of P. vagans C9-1 and of E. coli 
(pCIE85) were assayed in an MGA double diffusion agar 
system seeded with 2 × 106 cfu/ml of an indicator, as previ-
ously described (Ishimaru et al., 1988) The indicators used 
included E. amylovora CIR556, which is sensitive to her-
bicolin O and I, and its spontaneous herbicolin-resistant 
derivatives, E. amylovora CIR555 (herbicolin ORIS) and 
E. amylovora CIR550 (herbicolin OSIR), as previously de-
scribed (Kamber et al., 2012). Antibacterial activity was 
recorded as formation of clear zones of inhibition in bacte-
rial lawns after incubation for 2 days at 26°C.
DNA isolation and manipulation. Plasmid DNA was 
isolated on a small scale by an alkaline mini-prep extrac-
tion procedure. Cosmid DNA was isolated according to 
the “very low copy” plasmid isolation procedure supplied 
by Qiagen (Santa Clarita, CA, USA). DNA T4 ligase was 
obtained from GIBCO BRL (Gaithersburg, MD, USA), 
and ligation of DNA was carried out as recommended by 
the manufacturer. Genomic DNA of P. vagans C9-1 was 
obtained by the CTAB method developed for Gram-neg-
ative bacterial genomic DNA extraction (Wilson, 2001). 
Restriction endonucleases were purchased from Promega 
Corp. (Madison, WI, USA) and digestion of DNA was car-
ried out as recommended by the manufacturer.
Genomic library construction and screening. A cosmid 
library with inserts of about 25 kb was made in cloning 
vector pLAFR3 (22 kb) (Staskawicz et al., 1987). This vec-
tor included genes for mobilization in E. coli, tetracycline 
resistance, and the lacZ gene for selection of inserts by 
blue/white selection. Plasmid pLAFR3 was maintained in 
E. coli strain HB101. Approximately 5 μg of pLAFR3 DNA 
was digested with BamHI and dephosphorylated with bac-
terial alkaline phosphatase. The dephosphorylated vector 
was ligated using T4 ligase to the sized fragments of P. 
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vagans C9-1 chromosomal DNA (1 μg) partially digested 
with Sau3A1. Ligated DNA was packaged using Gigapack 
II from Stratagene (now Agilent Technologies, Santa Clara, 
CA, USA) and amplified in E. coli DH5α. Individual 
clones of the cosmid library were assayed for antimicrobial 
activity, as described above. Clones were grown on MGA 
with tetracycline for 2 days at 26°C. Colonies were killed 
with chloroform vapor and overlaid with E. amylovora 
CIR576, a tetracycline resistant derivative of E. amylovora 
CIR556, to maintain tetracycline selection for pLAFR3 
cosmids. E. amylovora CIR576 was created by a triparental 
mating between E. coli HB101 (pRK252), E. coli HB101 
(pRK2013), and E. amylovora CIR556. E. amylovora trans-
conjugants were selected on LB agar supplemented with 
tetracycline hydrochloride and rifampicin.
In vitro mutagenesis of herbicolin O biosynthesis 
genes. EZ::TN™ (Epicenter) was used for in vitro mu-
tagenesis of the herbicolin O-producing cosmid clone, 
pCIE85, according to the manufacturer’s procedure. The 
transposition reaction was incubated at 37°C for 2 h and 
then stopped with SDS. Competent cells of E. coli DH5α 
were electroporated according to standard electropora-
tion conditions for E. coli. E. coli (pCIE85::Tn<Kan2>) 
mutants were selected on the basis of resistance to kana-
mycin. Mutants were bioassayed for altered herbicolin O 
production, as described previously (Kamber et al., 2012). 
The mutants were tested for activity against E. amylovora 
CIR556, E. amylovora CIR550, and E. amylovora CIR555 
(Kamber et al., 2012). In addition, antibiotics produced by 
the E. coli (pCIE85::Tn<Kan2>) mutants were screened 
for histidine reversal by adding histidine to the overlay 
medium seeded with the herbicolin O sensitive indicator, 
E. amylovora CIR550. Mutant phenotypes were verified 
by repeating the assays at least three times. All putative 
antibiotic deficient mutants were stored in glycerol at 
−80°C for future use.
Localization of EZ::TN™ insertions. Herbicolin O-de-
ficient mutants were analyzed for the location and number 
of insertions by a combination of sequencing and Southern 
hybridization. Cosmid DNA preparations were digested 
with either EcoRI, which cuts outside of the borders of 
the EZ::TN insert, or HindIII, which cuts within the in-
sert. For cosmid mutants, 1 μg of DNA was digested and 
separated by agarose gel electrophoresis, transferred to 
nylon membranes and probed with the EZ::TN insertion 
sequence labeled with digoxigenin-dUTP, according to 
protocols supplied with a DIG-High Prime Lab kit. DNA 
flanking the site of transposon inserts was sequenced using 
inverse primers supplied with the EZ::TN transposon. Big 
dye terminator cycle sequencing was performed on an ABI 
Prism 310 using standard manufacturer procedures (Ap-
plied Biosystems Inc., Foster City, CA, USA). Sequences 
for herbicolin O biosynthesis were located within the pub-
lished genome sequence of P. vagans C9-1 (Smits et al., 
2010) using the Lasergene Package (DNAStar, Madison, 
WI, USA). Comparisons to pantocin A biosynthesis genes 
and to the corresponding region in P. agglomerans ATCC 
27155T were completed as previously described (Kamber 
et al., 2012).
Isolation and structural analysis of histidine-sensitive 
antibiotic from CIE85. E. coli DH5α (pCIE85) was pre-
grown in MGA broth supplemented with 20 μg/ml tetracy-
cline to an OD620 of 0.1 and used to create a 200 ml broth 
seed culture for large-scale antibiotic production in 10 l of 
MGA. Cells were fermented at 26°C for 15.5 h with main-
tenance of pH at 7.0 at the Colorado Bioprocessing Center 
(Fort Collins, CO). Cells were removed and the resultant 
supernatant was collected, concentrated by evaporation, 
and stored at −20°C. All herbicolin O-containing samples 
and fractions were collected and kept on ice during each 
procedure to retain bioactivity. For purification, samples 
were adjusted quickly to a pH 2.5-3.0 with sulfuric acid pri-
or to cation exchange (Ag50 W-Y4, NH4 + 2.5mM, pH 5). 
After elution with 20 mM ammonium acetate (pH 5) and 
desalting (ENVI™-Carb Packing 60 ml, 10 g cartridge; 
Supelco, Bellefonte, PA) as per the manufacturer’s in-
structions, bioactive fractions were further separated by 
preparative and semi-preparative hydrophilic interaction 
(HILIC) (polyhydroxyethyl aspartimide™, PolyLC Inc., 
Columbia, MD, USA) in gradients containing acetonitrile, 
followed by desalting and concentration. Finally, antibiotic 
active fractions were separated by size exclusion chroma-
tography with a polyhydroxyethyl aspartamide™ column 
(250 × 49.4 mm, 5 μm, 60 Å, PolyLC Inc.) equilibrated in 
50 mM 1,1,1,3,3,3-hexafluoro-2-propanol (HF2P) (Aldrich, 
Milwaukee, WI, USA). Briefly, dry herbicolin O powder 
was resuspended completely in 1 ml cold HPLC grade 
H2O and adjusted to 50 mM HF2P immediately prior 
to injection the column. Isocratic separation of bioactive 
peaks was accomplished in 50 mM HF2P at a flow rate of 
0.4 ml/min. The absorbance was monitored with a photo-
diode array detector at 214-350 nm. Peaks with a retention 
time of approximately 42-46 min were collected, placed on 
ice, and immediately adjusted to pH 6-7 with 0.1 M ammo-
nium hydroxide. The collected peaks were concentrated 
and desalted. Fractions with antimicrobial activity were 
lyophilized to dryness and stored at −20°C. Purified her-
bicolin O was analyzed by a combination of 1H NMR and 
other NMR experiments, as previously described (Jin et 
al., 2003).
Temperature regulation of antibiotics from P. vagans 
C9-1. Herbicolin O producers P. vagans C9-1 and E. coli 
(pCIE85) were grown on LB agar plates and incubated 
at 26°C and 37°C, respectively, for 24 h. Cell suspensions 
containing about 108 cfu/ml were made in potassium phos-
phate buffer (20 mM, pH 7.2). Ten μl of each producer was 
spotted onto MGA agar plates and incubated at either 
26°C, 33°C or 37°C for 48 h. Viable bacteria were killed 
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with chloroform vapor and overlaid with indicator strains 
varying in sensitivity to herbicolin I and herbicolin O, as 
described above. Antibacterial activity was recorded as 
formation of clear zones of inhibition after incubation for 
2 days at 26°C.
RESULTS
Functional analysis of the P. vagans C9-1 herbicolin 
O biosynthetic cluster. One out of 2000 clones from a 
cosmid library of P. vagans C9-1 produced a zone of inhi-
bition in lawn of the indicator E. amylovora CIR556. This 
activity was not present when histidine had been added to 
the overlay medium. The genes for antibiotic biosynthesis 
in this clone, E. coli DH5α (pCIE85), were delineated by 
directed mutagenesis with EZ::TN and sequencing. A total 
of 300 EZ::TN insertion mutants were screened for loss of 
herbicolin O production. Twenty-six mutations resulted 
in loss of herbicolin O on MGA medium. Southern hy-
bridization experiments verified that all mutants contained 
single insertions of the transposon. Insertions associated 
with loss of function were localized within a 12.6 kb EcoRI 
fragment. The flanking DNA sequences of five transposon 
insertion sites (188, 189, 192, 193 and 201) associated with 
loss of herbicolin O production were obtained (Fig. 1). The 
overlapping sequences provided a complete sequence of 
the herbicolin O operon. Both the nucleotide sequences 
and the deduced amino acid sequences of the herbicolin O 
operon were highly similar to the promoter, pre-peptide, 
and paaABC gene sequences involved in the biosynthesis 
of pantocin A (Jin et al., 2003).
Herbicolin O biosynthesis cluster in P. vagans C9-
1. Comparisons between the EZ::TN insertions and the 
complete genome sequence of P. vagans C9-1 revealed that 
the genes required for herbicolin O biosynthesis are co-
located on a 28-kb low G+C% genomic island containing 
the paaABC gene cluster. The genomic island present in 
P. vagans C9-1 containing paaABC genes was absent from 
the type strain P. agglomerans ATCC 27155, which does 
not produce the antibiotic (Fig. 1).
Isolation and structural identification of herbicolin 
O. The histidine-sensitive antibiotic produced by P. va-
gans C9-1 was isolated to homogeneity by a combination 
of chromatographic steps. The purity of the sample was 
confirmed by the presence of a single peak with charac-
teristic dual absorption maxima at 214 and 275 nm in size 
exclusion HPLC chromatograms. The 1H NMR spectra 
of herbicolin O closely resembled those of the bacterial 
metabolite pantocin A, and a more detailed analysis was 
undertaken to pinpoint any significant differences (Jin et 
al., 2003). Detailed analysis of the proton spin systems via 
a dqf-COSY NMR experiment showed that the chemi-
cal shift values and coupling constants of the protons in 
herbicolin O corresponded exactly to those of pantocin A, 
suggesting that pantocin A and herbicolin O are identical. 
This dqf-COSY result was corroborated via an HMQC 
NMR experiment, which allowed for the assignment of all 
proton-bearing carbons in herbicolin O. Again, these data 
exactly matched those of pantocin A (data not shown). All 
measurements were within experimental error supporting 
the conclusion that herbicolin O is identical to pantocin 
A (Fig. 2).
Fig. 1. Genomic island in P. vagans C9-1 containing the pantocin A gene cluster paaABC. Black vertical arrows indicate the loss 
of antibiotic production (188, 189, 192, 193 and 201) by transposon insertions located within the herbicolin O-producing cosmid 
clone, E. coli DH5α (pCIE85). The P. vagans C9-1 genomic island containing paaABC is absent from the corresponding genomic 
region of P. agglomerans ATCC 27155T.
Fig. 2. Chemical structure of pantocin A and herbicolin O.
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Temperature effects on antibiotic production and 
stability. The effect of temperature on the production of 
herbicolin peptide antibiotics was studied in vitro. The 
production of herbicolin O and I by P. vagans C9-1 was 
greatest at 26°C. Herbicolin O and I production was mark-
edly reduced at 33°C and abolished at 37°C (Table 1). In 
contrast, production of herbicolin O by E. coli (pCIE85) 
was comparable at 26°C and 37°C (Table 1).
To determine the stability of herbicolin O, aliquots of 
purified herbicolin O were incubated at room temperature 
(20-23°C) for up to three days. The titer of herbicolin O 
was determined by bioassay with the herbicolin O and I 
sensitive indicator E. amylovora CIR556. No decrease in 
antibiotic activity was detected after 3-days of incubation 
(data not shown).
DISCUSSION
When first described, Pantoea vagans C9-1 was named 
Erwinia herbicola, in keeping with the taxonomy at the 
time (Ishimaru et al., 1988). The antimicrobial activities 
produced in vitro by strain C9-1 were named “herbicolins” 
after the species epithet “herbicola”. Three antimicrobial 
activities were characterized by a combination of in vitro 
assays using whole cells or partially purified preparations 
of the antibiotics. Herbicolin O inhibited the growth of E. 
amylovora and several members of the Enterobacteriaceae, 
while herbicolin I inhibited only E. amylovora and Staphy-
lococcus aureus, under certain conditions. Another antibi-
otic produced, herbicolin 2C, seemed to have the same an-
timicrobial spectrum as herbicolin O. Initially, herbicolins 
O, I, and 2C were thought to be distinct structurally from 
other antibiotics produced by other Erwinia herbicola/Pan-
toea agglomerans strains with biocontrol activity against 
fire blight. One reason for this was an early report that 
partially purified herbicolins were sensitive to beta-lacta-
mase and therefore belonged to the beta-lactam class of 
antibiotics (Ishimaru et al., 1988). However, the presence 
of a beta-lactam ring claim was not supported by infrared 
spectroscopy (data not shown). Stockwell et al. found that 
commercially available β-lactamase preparations contain 
substantial protease activity (V. Stockwell, unpublished 
information). Repeated assays with highly purified prepa-
rations of herbicolin O and I against high quality enzyme 
preparations did not demonstrate beta-lactamase sensitiv-
ity (data not shown). Thus, the inactivation of herbicolin 
O and I reported in the earlier study was likely due to 
protease and not beta-lactamase activity.
Temperature is one factor affecting in vitro expression 
of herbicolin O in P. vagans C9-1 and other related anti-
biotics (Vanneste et al., 2008; Jin et al., 2003). Herbicolin 
O production by P. vagans C9-1 is inhibited at tempera-
tures above the bacterium’s optimal growth temperature of 
26°C. Since elevated temperature did not affect herbicolin 
O production by E. coli pCIE85, the loss of herbicolin O 
activity observed with P. vagans C9-1 is not due to instabil-
ity of herbicolin O at elevated temperatures. This conclu-
sion is further supported by the observation that purified 
herbicolin O is stable at ambient temperatures for several 
days. Future studies on the effects of temperature on in 
planta regulation of pantocin A gene expression could aid 
in identifying environmental conditions that promote bio-
logical control of fire blight.
Knowledge of the diversity and novelty of antibiotics 
produced by common members of the microbial commu-
nity in apples and pears has expanded greatly since the 
first reports of biocontrol of fire blight. It has become 
clear that while there are notable differences, similarities 
exist among the antibiotics produced by isolates indepen-
dently selected for fire blight biocontrol activity. In the 
case of histidine-reversible antibiotics, obvious functional 
similarities occur among those produced by P. agglomer-
ans Eh318, P. agglomerans Eh252, and P. vagans C9-1. In 
this report we have determined the structure of herbicolin 
O to be identical to that of pantocin A. This conclusion is 
Table 1. Temperature regulation of herbicolin O and I production in Pantoea vagans C9-1.
Producera Erwinia amylovora indicator strainb Temperature (°C) Herbicolin O inhibition zone (mm) Herbicolin Ic inhibition zone (mm)
P. vagans C9-1 CIR556 (OSIS) 26 40 20
33 33 15
37 0 0
CIR555 (ORIS) 26 0 25
33 0 12
37 0 0
CIR550 (OSIR) 26 39 0
33 41 0
37 0 0
E. coli (pCIE85) CIR 556 (OSIS) 26 30 NAd
37 35 NA
 a Producers were grown on MGA agar medium and assayed for antimicrobial activity as described in methods.
 b Indicators CIR555 and CIR550 were previously described derivatives of Erwinia amylovora CIR556 selected for sensitivity (S) or resistance (R) to 
herbicolin O or herbicolin I.
 c Herbicolin I = 2-amino-3-(oxirane-2,3-dicarboxamido)-propanoyl-valine (APV)
 d Not applicable; E. coli (pCIE85) produces only herbicolin O.
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also supported by heterologous expression and directed 
mutagenesis of the paaABC orthologous gene cluster in P. 
vagans C9-1, where loss of herbicolin O production was 
associated with transposon insertions in paaABC. Thus, in 
all respects, pantocin A and herbicolin O are analogous. 
In the future, it is recommended that the histidine-revers-
ible antibiotic produced by P. vagans C9-1 be referred to 
as pantocin A.
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